Who did 4basebio add to its Strategic Advisory Board in June 2026?

In June 2026 4basebio added Dr Jeff Coller to its Strategic Advisory Board; his expertise in mRNA stability and translation is intended to inform template design and manufacturing as the company scales.

What Clinical Supply Agreement did 4basebio sign in May 2026?

In May 2026 4basebio signed a multi‑year Clinical Supply Agreement to provide GMP-grade opDNA® as starting material for a Phase II cancer immunotherapy trial and expects near‑term seven‑figure revenue from that work.

When did Cornel Chiriac join 4basebio as a non-executive director?

Cornel Chiriac joined 4basebio as a non-executive director on 8 July 2026.

4basebio — TickStock

Timeline

Health & Bio Today: AstraZeneca's Truqap wins FDA approval for prostate cancer

17:04, 15 Jun 2026

4basebio appoints Dr Jeff Coller to Strategic Advisory Board

08:22, 15 Jun 2026

4basebio wins opDNA supply deal for Phase II immunotherapy trial

07:16, 21 May 2026

4basebio launches enzymatic ssDNA platform

23:17, 11 May 2026

More in Healthcare

A laboratory technician is performing an analysis in a lab setting, wearing protective gear and using pipettes. The workspace features various laboratory equipment and samples, emphasizing a research environment.

Pharma

Hansoh Phase III win bolsters GSK's global case for Ris-Rez in lung cancer

Positive overall survival data from a China trial of risvutatug rezetecan marks the first Phase III success for any B7-H3-targeted antibody-drug conjugate, strengthening GSK's broader development programme.

Updated 14:01, 10 Jul 2026